The Department of Health is offering this grant to enhance newborn screening laboratory capabilities across states and territories. This grant aims to significantly increase the number of public health facilities capable of detecting Severe Combined Immunodeficiency (SCID) and other primary immunodeficiencies. This grant is for integrating advanced next-generation sequencing technologies into routine screening processes. Funding will support the necessary technological upgrades, staff training, and infrastructure development. The purpose is to ensure more widespread and efficient early diagnosis. This will improve health outcomes for affected newborns nationwide, strengthening public health’s capacity to identify and manage severe inherited disorders promptly.
Opportunity ID: 292910
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-EH17-1703 |
Funding Opportunity Title: | Increasing Newborn Screening Laboratory Capability to Detect Severe Combined Immunodeficiency (SCID) Using Next Generation Sequencing Technologies |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 4 |
Assistance Listings: | 93.065 — Laboratory Leadership, Workforce Training and Management Development, Improving Public Health Laboratory Infrastructure |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Mar 31, 2017 |
Last Updated Date: | Mar 31, 2017 |
Original Closing Date for Applications: | May 31, 2017 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
Current Closing Date for Applications: | May 31, 2017 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
Archive Date: | Jun 30, 2017 |
Estimated Total Program Funding: | $600,000 |
Award Ceiling: | $150,000 |
Award Floor: | $150,000 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | The authorizing statute allows awards to States, political subdivisions, and other public and nonprofit private entities. Further, awardees must represent or be an administrative partner to an established state or territorial newborn screening program that currently screens for SCID in a U.S. state or territory. Applicants should provide a letter certifying they represent or are an administrative partner to an established state or territorial newborn screening program. |
Additional Information
Agency Name: | Centers for Disease Control – NCEH |
Description: | To increase the number of states and territories with newborn screening public health laboratories capable of screening for SCID and other primary immunodeficiencies using next generation sequencing technologies. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Technical Information Management Section
CDC Office of Financial Resources Office of Grants Services 2920 Brandywine Road, MS E-14 Atlanta, GA 30341 Telephone: 770-488-2700 Email:ogstims@cdc.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
updated contact info | Mar 31, 2017 | |
Mar 31, 2017 |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-EH17-1703 |
Funding Opportunity Title: | Increasing Newborn Screening Laboratory Capability to Detect Severe Combined Immunodeficiency (SCID) Using Next Generation Sequencing Technologies |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 4 |
Assistance Listings: | 93.065 — Laboratory Leadership, Workforce Training and Management Development, Improving Public Health Laboratory Infrastructure |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Mar 31, 2017 |
Last Updated Date: | Mar 31, 2017 |
Original Closing Date for Applications: | May 31, 2017 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
Current Closing Date for Applications: | May 31, 2017 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
Archive Date: | Jun 30, 2017 |
Estimated Total Program Funding: | $600,000 |
Award Ceiling: | $150,000 |
Award Floor: | $150,000 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | The authorizing statute allows awards to States, political subdivisions, and other public and nonprofit private entities. Further, awardees must represent or be an administrative partner to an established state or territorial newborn screening program that currently screens for SCID in a U.S. state or territory. Applicants should provide a letter certifying they represent or are an administrative partner to an established state or territorial newborn screening program. |
Additional Information
Agency Name: | Centers for Disease Control – NCEH |
Description: | To increase the number of states and territories with newborn screening public health laboratories capable of screening for SCID and other primary immunodeficiencies using next generation sequencing technologies. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Technical Information Management Section
CDC Office of Financial Resources Office of Grants Services 2920 Brandywine Road, MS E-14 Atlanta, GA 30341 Telephone: 770-488-2700 Email:ogstims@cdc.gov |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-EH17-1703 |
Funding Opportunity Title: | Increasing Newborn Screening Laboratory Capability to Detect Severe Combined Immunodeficiency (SCID) Using Next Generation Sequencing Technologies |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 4 |
Assistance Listings: | 93.065 — Laboratory Leadership, Workforce Training and Management Development, Improving Public Health Laboratory Infrastructure |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Mar 31, 2017 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | May 31, 2017 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
Archive Date: | Jun 30, 2017 |
Estimated Total Program Funding: | $600,000 |
Award Ceiling: | $150,000 |
Award Floor: | $150,000 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | The authorizing statute allows awards to States, political subdivisions, and other public and nonprofit private entities. Further, awardees must represent or be an administrative partner to an established state or territorial newborn screening program that currently screens for SCID in a U.S. state or territory. Applicants should provide a letter certifying they represent or are an administrative partner to an established state or territorial newborn screening program. |
Additional Information
Agency Name: | Centers for Disease Control – NCEH |
Description: | To increase the number of states and territories with newborn screening public health laboratories capable of screening for SCID and other primary immunodeficiencies using next generation sequencing technologies. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Daniel Mandel
IBT7@cdc.gov Email:IBT7@cdc.gov |
Related Documents
Folder 292910 Full Announcement-Increasing Newborn Screening -> CDC-RFA-EH17-1703.pdf
Packages
Agency Contact Information: | Technical Information Management Section CDC Office of Financial Resources Office of Grants Services 2920 Brandywine Road, MS E-14 Atlanta, GA 30341 Telephone: 770-488-2700 Email: ogstims@cdc.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
93.065 | CDC-RFA-EH17-1703 | Increasing Newborn Screening Laboratory Capability to Detect Severe Combined Immunodeficiency (SCID) Using Next Generation Sequencing Technologies | PKG00231759 | Mar 28, 2017 | May 31, 2017 | View |
Package 1
Mandatory forms
292910 SF424_2_1-2.1.pdf
292910 SFLLL_1_2-1.2.pdf
292910 SF424A-1.0.pdf
292910 HHS_CheckList_2_1-2.1.pdf
292910 ProjectNarrativeAttachments_1_2-1.2.pdf
292910 BudgetNarrativeAttachments_1_2-1.2.pdf
Optional forms
292910 OtherNarrativeAttachments_1_2-1.2.pdf